| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |